BioLineRx Ltd. — AGM Information 2018

Apr 16, 2018

_________ false

������� �� ��� ��"�	2 380
BIOLINE RX LTD
Corporation no: 513398750	9253
- - -

	Israel Securities Authority			Tel Aviv Stock Exchange		C002 ( Public )		Reported via MAGNA:	16/04/2018
	www.isa.gov.il			www.tase.co.il				Reference:	2018-02-031329	Time of broadcast: 15:52 15:44:07

---

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

	Delay the publication of a report	_________	_________

1. The delay of the report can be done up to 72 hours maximum from the date of filling out the form.2. Attention that in accordance with the provisions of the law, the reporting date must be simultaneous with the report in the foreign exchange.

	The corporation is a foreign private issuer as defined by U.S. Securities Laws.

Attached hereto is a report onBioLineRx Announces Results of Annual General Meeting of Shareholders

6-K_AGM2018_results_isa.pdf

References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
2018-02-019290
- - -
Stock Exchange/Market: NASDAQ CM	Date of revision of form structure: 20/02/2018
Address: HaMa'ayan 2 , Modi'in 7177871   , Israel Tel: 08-6429100 , Fax: 08-6429101
E-mail address: info@BioLineRx.com   Company site: www.biolinerx.com
Previous names of reporting entity:
Name of the Signatory: Kotler Norman Harold Position of Signatory in the reporting corporation: General Counsel & Company Secretary Name of Employer Company:
Address: HaMa'ayan 2 , Modi'in 7177871 Telephone: 08-6429100 Facsimile: 08-6429101 E-mail: normank@biolinerx.com 1
Israel